OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
- PMID: 9834095
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
Abstract
We have cloned a TNFR family member from a follicular dendritic cell (FDC)-like cell line, FDC-1. This molecule, FDC-derived receptor-1 (FDCR-1), is identical to osteoprotegerin (OPG), a soluble cytokine that regulates osteoclast differentiation. Recently, OPG/FDCR-1 has been characterized as a second receptor for receptor activator of NF-kappaB ligand (RANKL)/TNF-related activation-induced cytokine (TRANCE), a primarily T-cell restricted TNF family member that augments dendritic cell (DC) function. In this report, we demonstrate that OPG/FDCR-1 is membrane bound on the surface of transfected baby hamster kidney (BHK) and untransfected FDC-1 cells. We also found a restricted OPG/FDCR-1 expression pattern in lymphoid cells, specifically in B cells, DCs and FDC-enriched fractions, which in B cells and DCs is up-regulated by CD40 stimulation. Because OPG/FDCR-1 shares some properties with RANK, the first RANKL/TRANCE receptor, we discuss how the balance between RANK and OPG/FDCR-1 expression could influence immune responses and, ultimately, germinal center formation.
Similar articles
-
Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.J Cell Biochem. 2002;86(4):642-50. doi: 10.1002/jcb.10242. J Cell Biochem. 2002. PMID: 12210731
-
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.Biochem Biophys Res Commun. 2000 Sep 7;275(3):768-75. doi: 10.1006/bbrc.2000.3379. Biochem Biophys Res Commun. 2000. PMID: 10973797
-
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent.J Cell Biochem. 2007 Apr 15;100(6):1430-9. doi: 10.1002/jcb.21129. J Cell Biochem. 2007. PMID: 17171649
-
Immune function of the decoy receptor osteoprotegerin.Crit Rev Immunol. 2002;22(3):201-15. Crit Rev Immunol. 2002. PMID: 12498383 Review.
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
Cited by
-
B Cell Production of Both OPG and RANKL is Significantly Increased in Aged Mice.Open Bone J. 2014;6:8-17. doi: 10.2174/1876525401406010008. Open Bone J. 2014. PMID: 25984250 Free PMC article.
-
TLR4 mediates alveolar bone resorption in experimental peri-implantitis through regulation of CD45+ cell infiltration, RANKL/OPG ratio, and inflammatory cytokine production.J Periodontol. 2020 May;91(5):671-682. doi: 10.1002/JPER.18-0748. Epub 2019 Nov 13. J Periodontol. 2020. PMID: 31489644 Free PMC article.
-
Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.Int Orthop. 2011 May;35(5):777-82. doi: 10.1007/s00264-010-1088-3. Epub 2010 Jul 11. Int Orthop. 2011. PMID: 20623281 Free PMC article.
-
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.Wien Med Wochenschr. 2011 Dec;161(23-24):565-70. doi: 10.1007/s10354-011-0022-7. Epub 2011 Sep 2. Wien Med Wochenschr. 2011. PMID: 21870142 Review.
-
Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.Front Immunol. 2017 Dec 22;8:1851. doi: 10.3389/fimmu.2017.01851. eCollection 2017. Front Immunol. 2017. PMID: 29312334 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials